<--- Back to Details
First PageDocument Content
Organic chemistry / Pharmacology / Eli Lilly and Company / Alcohols / Pharmacy / Anti-diabetic medication / Formulary / Pharmaceutical drug / Exenatide / Chemistry / Medicine / Anti-diabetic drugs
Date: 2012-12-20 16:16:40
Organic chemistry
Pharmacology
Eli Lilly and Company
Alcohols
Pharmacy
Anti-diabetic medication
Formulary
Pharmaceutical drug
Exenatide
Chemistry
Medicine
Anti-diabetic drugs

c Al.ll 1\JTIUN BfiOWAHD COUNl Y Mf]VH3L HS ca tamaran··

Add to Reading List

Source URL: www.broward.org

Download Document from Source Website

File Size: 1,07 MB

Share Document on Facebook

Similar Documents

Dipeptidyl peptidase-4 inhibitors / Eli Lilly and Company / Amides / Anti-diabetic drugs / Peptide hormones / Exenatide / Anti-diabetic medication / Sitagliptin / Saxagliptin / Metformin / Glucagon-like peptide-1 agonist / Sulfonylurea

Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES

DocID: 1oY1K - View Document

Sulfonylureas / Eli Lilly and Company / Glimepiride / Pyrrolines / Pioglitazone / Metformin / Exenatide / Glibenclamide / Acarbose

glimepiride contraindications glimepiride doses glimepiride dehydration side effects of glimepiride glimepiride forum glimepiride tabs dosage, glimepiride max dose 10mg, glimepiride 2mg

DocID: 1oLgD - View Document

Medicine / Eli Lilly and Company / Gastroenterology / Anti-diabetic drugs / Recombinant proteins / Exenatide / Anti-diabetic medication / Insulin analog / Insulin glargine / Endocrine system / Diabetes / Peptide hormones

OctoberINSULIN USE FOR TYPE 2 DIABETES MANAGEMENT WHAT INSULIN REGIMEN SHOULD

DocID: 1fAJ9 - View Document

BYDUREON (exenatide extended-release for injectable suspension).

DocID: 1dnVP - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA姞 (exenatide) Injection Initial

DocID: 1ccpM - View Document